Surgical management of ovarian cancer
- 1 July 1994
- journal article
- research article
- Published by Wiley in Seminars in Surgical Oncology
- Vol. 10 (4) , 268-275
- https://doi.org/10.1002/ssu.2980100407
Abstract
Although several surgical approaches to the diagnosis and management of epithelial ovarian cancer are now standard, surprisingly few prospective data exist to support many of these procedures. However, retrospective data have accumulated over the past decade, much of it very recent, which allow clinicians to make informed decisions regarding most of the commonly performed procedures. This review is an attempt to critically evaluate the best available data regarding the following procedures: primary surgical staging, primary cytoreductive surgery, second look laparotomy and secondary cytoreductive surgery, and palliative surgery for relief of bowel obstruction. We conclude that there is evidence to support the continued use of primary surgical staging and primary cytoreductive surgery. However, data in support of second look laparotomy and secondary cytoreductive surgery are lacking, and we recommend that these procedures not be performed on a routine basis. Finally, we conclude that palliative surgery is hazardous at best and results in questionable benefits for most patients.Keywords
This publication has 16 references indexed in Scilit:
- The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume Stage III epithelial ovarian cancer: A gynecologic oncology group studyGynecologic Oncology, 1992
- The role of cytoreductive surgery in the management of stage IV epithelial ovarian carcinomaGynecologic Oncology, 1992
- Meta-analysis of surgery in advanced ovarian carcinoma: Ismaximum cytoreductive surgery an independent determinant of prognosis?American Journal of Obstetrics and Gynecology, 1992
- Tumor reduction surgery and long-term survival in advanced ovarian cancer: A DACOVA studyGynecologic Oncology, 1990
- Adjuvant Therapy in Stage I and Stage II Epithelial Ovarian CancerNew England Journal of Medicine, 1990
- Evaluation of treatment and survival after positive second-look laparotomyGynecologic Oncology, 1988
- Primary or delayed debulking surgery and chemotherapy consisting of cisplatin, doxorubicin, and cyclophosphamide in stage III-IV epithelial ovarian carcinoma.Journal of Clinical Oncology, 1986
- Cytoreductive Surgery in Ovarian CarcinomaObstetrics & Gynecology, 1986
- Debulking surgery: Does it increase the quality of survival?Gynecologic Oncology, 1982
- Second-look operations in ovarian cancerAmerican Journal of Obstetrics and Gynecology, 1980